Dutch Institute for Clinical Auditing, Scientific Bureau, Leiden, the Netherlands; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands.
Department of Biomedical Data Sciences, LUMC, Leiden, the Netherlands.
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):649-659. doi: 10.1016/j.ejso.2020.10.016. Epub 2020 Oct 16.
Differences in patient demographics and disease burden can influence comparison of hospital performances. This study aimed to provide a case-mix model to compare short-term postoperative outcomes for patients undergoing liver resection for colorectal liver metastases (CRLM).
This retrospective, population-based study included all patients who underwent liver resection for CRLM between 2014 and 2018 in the Netherlands. Variation in case-mix variables between hospitals and influence on postoperative outcomes was assessed using multivariable logistic regression. Primary outcomes were 30-day major morbidity and 30-day mortality. Validation of results was performed on the data from 2019.
In total, 4639 patients were included in 28 hospitals. Major morbidity was 6.2% and mortality was 1.4%. Uncorrected major morbidity ranged from 3.3% to 13.7% and mortality ranged from 0.0% to 5.0%. between hospitals. Significant differences between hospitals were observed for age higher than 80 (0.0%-17.1%, p < 0.001), ASA 3 or higher (3.3%-36.3%, p < 0.001), histopathological parenchymal liver disease (0.0%-47.1%, p < 0.001), history of liver resection (8.1%-36.3%, p < 0.001), major liver resection (6.7%-38.0%, p < 0.001) and synchronous metastases (35.5%-62.1%, p < 0.001). Expected 30-day major morbidity between hospitals ranged from 6.4% to 11.9% and expected 30-day mortality ranged from 0.6% to 2.9%. After case-mix correction no significant outliers concerning major morbidity and mortality remained. Validation on patients who underwent liver resection for CRLM in 2019 affirmed these outcomes.
Case-mix adjustment is a prerequisite to allow for institutional comparison of short-term postoperative outcomes after liver resection for CRLM.
患者人口统计学特征和疾病负担的差异可能会影响医院绩效的比较。本研究旨在为结直肠癌肝转移患者行肝切除术的短期术后结局提供一种病例组合模型。
本回顾性基于人群的研究纳入了 2014 年至 2018 年期间在荷兰行肝切除术治疗结直肠癌肝转移的所有患者。使用多变量逻辑回归评估医院之间病例组合变量的差异及其对术后结局的影响。主要结局为 30 天主要发病率和 30 天死亡率。在 2019 年的数据上进行了结果验证。
共纳入 28 家医院的 4639 例患者。主要发病率为 6.2%,死亡率为 1.4%。未经校正的主要发病率范围为 3.3%至 13.7%,死亡率范围为 0.0%至 5.0%。各医院间存在显著差异。80 岁以上(0.0%-17.1%,p<0.001)、ASA 3 或更高(3.3%-36.3%,p<0.001)、组织病理学实质肝脏疾病(0.0%-47.1%,p<0.001)、肝切除术史(8.1%-36.3%,p<0.001)、大肝切除术(6.7%-38.0%,p<0.001)和同步转移(35.5%-62.1%,p<0.001)的差异有统计学意义。医院间预期 30 天主要发病率范围为 6.4%至 11.9%,预期 30 天死亡率范围为 0.6%至 2.9%。病例组合校正后,主要发病率和死亡率无显著离群值。对 2019 年行肝切除术治疗结直肠癌肝转移的患者进行验证,结果得到证实。
病例组合调整是允许对结直肠癌肝转移患者行肝切除术的短期术后结局进行机构间比较的前提。